TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/15/23 11:03 | 5/11/23 | PRGO | Perrigo Co Plc | L2 | Health | Drug | Pharmaceutical Preparations | Kessler Murray S | FL | DO | CEO | S | -7,066 | 35.75 | 0 | -198 | -99 | 3 | D | ||||||||||||||
3/8/23 16:56 | 3/7/23 | PRGO | Perrigo Co Plc | L2 | Health | Drug | Pharmaceutical Preparations | Kessler Murray S | FL | DO | CEO | M.d | 1,018 | 37.71 | 0 | 27 | 16 | 200 | D | ||||||||||||||
3/7/23 15:31 | 3/3/23 | PRGO | Perrigo Co Plc | L2 | Health | Drug | Pharmaceutical Preparations | Kessler Murray S | FL | DO | CEO | M.d | 1,277 | 38.75 | 0 | 33 | 22 | 185 | D | ||||||||||||||
3/8/22 16:55 | 3/4/22 | PRGO | Perrigo Co Plc | L2 | Health | Drug | Pharmaceutical Preparations | Kessler Murray S | FL | DO | CEO | M.d | 1,836 | 37.23 | 0 | 49 | 69 | 121 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |